ARTICLE | Company News
Palatin, Competitive Technologies Inc. genitourinary news
June 27, 2005 7:00 AM UTC
The companies settled their previously announced arbitration related to a 1997 license agreement for PTN to exclusively use CTT's Erectide peptide hormone analog in PTN's PT-141 erectile dysfunction ...